Skip to main content
SpringerLink
Log in

Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients

  • Investigative report
  • Published:
European Journal of Dermatology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hartung HP, Montalban X, Sorensen PS, Vermersch P, Olsson T. Principles of a new treatment algorithm in multiple sclerosis. Expert Rev Neurother 2011; 11: 351–62.

    Article  PubMed  Google Scholar 

  2. Balak DM, Hengstman GJ, Çakmak A, Thio HB. Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review. Mult Scler 2012; 18: 1705–17.

    Article  PubMed  Google Scholar 

  3. Bosca I, Bosca M, Belenguer A, et al. Necrotising cutaneous lesions as a side effect of glatiramer acetate. J Neurol 2006; 253: 1370–1.

    Article  PubMed  Google Scholar 

  4. Feldmann R, Schierl M, Rauschka H, Sator PG, Breier F, Steiner A. Necrotizing skin lesions with involvement of muscle tissue after subcutaneous injection of glatiramer acetate. Eur J Dermatol 2009; 19: 385.

    PubMed  Google Scholar 

  5. Harde V, Schwarz T. Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate. J Dtsch Dermatol Ges 2007; 5: 1122–3.

    Article  PubMed  Google Scholar 

  6. Gaudez C, Regnier S, Aractingi S, Heinzlef O. Livedo-like dermatitis (Nicolau’s syndrome) after injection of Copolymer-1 (Glatiramer acetate). Rev Neurol (Paris) 2003; 159: 571–3.

    CAS  Google Scholar 

  7. Martínez-Morán C, Espinosa-Lara P, Nájera L, et al. Embolia cútis medicamentosa (síndrome de Nicolau) trasinyección de acetado de glatirámero. Actas Dermosifiliogr 2011; 102: 742–4.

    Article  PubMed  Google Scholar 

  8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–52.

    Article  CAS  PubMed  Google Scholar 

  9. Kluger N, Thouvenot E, Camu W, Guillot B. Cutaneous adverse events related to glatiramer acetate injection (copolymer-1, Copaxone). J Eur Acad Dermatol Venereol 2009; 23: 1332–3.

    Article  CAS  PubMed  Google Scholar 

  10. Frohman EM, Brannon K, Alexander S, et al. Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management. MultScler 2004; 10: 302–7.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Department, Centro Hospitalar do Porto — Hospital Santo António, Porto, Portugal

    Raquel Samões & Ana Martins Silva

  2. Dermatology Department, Centro Hospitalar do Porto — Hospital Santo António, Porto, Portugal

    Sandrina Carvalho, Rosário Alves & Tiago Torres

Authors
  1. Raquel Samões
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandrina Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosário Alves
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tiago Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Martins Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raquel Samões.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samões, R., Carvalho, S., Alves, R. et al. Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients. Eur J Dermatol 24, 411–412 (2014). https://doi.org/10.1684/ejd.2014.2349

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2014.2349

Keywords

Search

Navigation